Ubs Group Ag Abcam PLC Transaction History

Ubs Group Ag

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$21.54 - $24.41 $9.22 Million - $10.4 Million	427,848 Added 711.23%	488,004 $11 Million
Q2 2023 Aug 11, 2023	BUY	$12.62 - $24.47 $631,214 - $1.22 Million	50,017 Added 493.31%	60,156 $1.47 Million
Q1 2023 May 12, 2023	BUY	$12.98 - $17.1 $76,452 - $100,719	5,890 Added 138.62%	10,139 $136,000
Q4 2022 Feb 08, 2023	BUY	$13.92 - $17.0 $49,610 - $60,588	3,564 Added 520.29%	4,249 $66,000
Q3 2022 Nov 10, 2022	BUY	$13.36 - $16.75 $7,187 - $9,011	538 Added 365.99%	685 $10,000
Q2 2022 Aug 10, 2022	SELL	$12.69 - $19.25 $12,423 - $18,845	-979 Reduced 86.94%	147 $2,000
Q1 2022 May 16, 2022	BUY	$15.5 - $23.89 $17,453 - $26,900	1,126 New	1,126 $20,000
Q3 2021 Nov 15, 2021	SELL	$17.38 - $21.54 $3,562 - $4,415	-205 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$18.47 - $22.11 $4,211 - $5,041	-228 Reduced 52.66%	205 $4,000
Q1 2021 May 12, 2021	BUY	$19.22 - $24.3 $8,322 - $10,521	433 New	433 $8,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.